Mitiglinide-RS benzyl succinic acid is a chiral impurity derived from the antidiabetic agent mitiglinide, featuring a benzyl-substituted succinic acid moiety linked via esterification to the parent compound's butyrolactam ring. The RS configuration at the chiral center introduces stereochemical complexity, while the succinic acid ester introduces a dicarboxylic acid functionality, differing from mitiglinide's guanidine group. This impurity arises via nucleophilic attack of benzyl alcohol on mitiglinide's electrophilic carbonyl during synthetic oxidation steps. Functions as an HPLC reference standard for enantiomeric purity analysis in mitiglinide API manufacturing.
On Request